---
layout: default
title: Scaling Tumor Segmentation: Best Lessons from Real and Synthetic Data
---

# Scaling Tumor Segmentation: Best Lessons from Real and Synthetic Data

**arXiv**: [2510.14831v1](https://arxiv.org/abs/2510.14831) | [PDF](https://arxiv.org/pdf/2510.14831.pdf)

**ä½œè€…**: Qi Chen, Xinze Zhou, Chen Liu, Hao Chen, Wenxuan Li, Zekun Jiang, Ziyan Huang, Yuxuan Zhao, Dexin Yu, Junjun He, Yefeng Zheng, Ling Shao, Alan Yuille, Zongwei Zhou

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºAbdomenAtlas 2.0æ•°æ®é›†ï¼Œç»“åˆçœŸå®žä¸Žåˆæˆæ•°æ®æå‡è‚¿ç˜¤åˆ†å‰²æ•ˆçŽ‡**

**å…³é”®è¯**: `è‚¿ç˜¤åˆ†å‰²` `åˆæˆæ•°æ®` `åŒ»å­¦å½±åƒ` `æ•°æ®æ‰©å±•` `ä½“ç´ æ ‡æ³¨`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. è‚¿ç˜¤åˆ†å‰²AIå—é™äºŽç¼ºä¹å¤§è§„æ¨¡ä½“ç´ æ ‡æ³¨æ•°æ®ï¼Œæ ‡æ³¨å›°éš¾ä¸”éœ€ä¸“å®¶å‚ä¸Ž
2. åˆ©ç”¨åˆæˆæ•°æ®å¯å‡å°‘çœŸå®žæ•°æ®éœ€æ±‚ï¼Œåœ¨JHHæ•°æ®é›†ä¸­ä»¥500çœŸå®žæ‰«æè¾¾åˆ°1500æ‰«ææ€§èƒ½
3. AbdomenAtlas 2.0åŒ…å«10,135 CTæ‰«æï¼Œåœ¨å…­å™¨å®˜åˆ†å‰²ä¸­DSCæå‡7%ï¼ˆåˆ†å¸ƒå†…ï¼‰å’Œ16%ï¼ˆåˆ†å¸ƒå¤–ï¼‰

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> AI for tumor segmentation is limited by the lack of large, voxel-wise
> annotated datasets, which are hard to create and require medical experts. In
> our proprietary JHH dataset of 3,000 annotated pancreatic tumor scans, we found
> that AI performance stopped improving after 1,500 scans. With synthetic data,
> we reached the same performance using only 500 real scans. This finding
> suggests that synthetic data can steepen data scaling laws, enabling more
> efficient model training than real data alone. Motivated by these lessons, we
> created AbdomenAtlas 2.0--a dataset of 10,135 CT scans with a total of 15,130
> tumor instances per-voxel manually annotated in six organs (pancreas, liver,
> kidney, colon, esophagus, and uterus) and 5,893 control scans. Annotated by 23
> expert radiologists, it is several orders of magnitude larger than existing
> public tumor datasets. While we continue expanding the dataset, the current
> version of AbdomenAtlas 2.0 already provides a strong foundation--based on
> lessons from the JHH dataset--for training AI to segment tumors in six organs.
> It achieves notable improvements over public datasets, with a +7% DSC gain on
> in-distribution tests and +16% on out-of-distribution tests.

